DLD anticorps
Aperçu rapide pour DLD anticorps (ABIN2719487)
Antigène
Voir toutes DLD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens dihydrolipoamide dehydrogenase (DLD)
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human DLD(NP_000099) produced in HEK293T cell.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- WB 1:2000, IF 1:100, FLOW 1:100,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
-
Autre désignation
- DLD
-
Sujet
- This gene encodes the L protein of the mitochondrial glycine cleavage system. The L protein, also named dihydrolipoamide dehydrogenase, is also a component of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acide dehydrogenase complex. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency.
-
Poids moléculaire
- 50.1 kDa
-
ID gène
- 1738
-
NCBI Accession
- NM_000108
-
HGNC
- 1738
-
Pathways
- Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis
Antigène
-